解整合素金属蛋白酶28(ADAM28)多克隆抗体
Polyclonal Antibody to A Disintegrin And Metalloprotease 28 (ADAM28)
ADAM23; MDCL; eMDCII; Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L; Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II
- 编号PAK202Hu01
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原 RPK202Hu01-解整合素金属蛋白酶28(ADAM28)重组蛋白
- 缓冲液成份磷酸盐缓冲液(pH7.4,含有0.02% NaN3和50%甘油)
- 性状液体
- 浓度500µg/mL
- 且适物种-
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 630 ¥ 1470 ¥ 2100 ¥ 5250 ¥ 21000
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
该抗体是针对ADAM28的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别ADAM28。
用法
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
RPK202Hu01 | 解整合素金属蛋白酶28(ADAM28)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAK202Hu01 | 解整合素金属蛋白酶28(ADAM28)多克隆抗体 | WB; IHC; ICC; IP. |
MAK202Hu21 | 解整合素金属蛋白酶28(ADAM28)单克隆抗体 | WB; IHC; ICC; IP. |
SEK202Hu | 解整合素金属蛋白酶28(ADAM28)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMK202Hu | 解整合素金属蛋白酶28(ADAM28)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
Rapid Communications in Mass Spectrometry | Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma [Pubmed: 21913264] |
Medical Oncology | Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor [SpringerLink: kg628446760r60rl] |
Immunology & Cell Biology | ADAM28 is elevated in humans with the metabolic syndrome and is a novel sheddase of human tumour necrosis factor-α. [PubMed: 23010875] |
Leuk Res | ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in [PubMed: 26340916] |
Disease Markers | Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results [Pubmed: 31565100] |
留言咨询